FDA
approval
· 2016-09-26
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide from Aurobindo Pharma Limited. The product is…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)